Article

EZH2 synergizes with BRD4-NUT to drive NUT carcinoma growth through silencing of key tumor…

medRxiv · 2023 · Huang, Y.; Durall, R. T.; Luong, N. M.; Hertzler, H. J.; Huang, J.; Gokhale, P. C.; Leeper, B. A.; Persky, N. S.; Root, D. E.; Anekal, P. V.; Montero Llopis, P. D.; David, C. N.; Kutok, J. L.; Raimondi, A.; Saluja, K.; Luo, J.; Zahnow, C. A.; Adane, B.; Stegmaier, K.; Hawkins, C. E.; Ponne, C.; Le, Q.; Shapiro, G. I.; Lemieux, M. E.; Eagen, K. P.; French, C. A.

Key facts

Title EZH2 synergizes with BRD4-NUT to drive NUT carcinoma growth through silencing of key tumor suppressor genes
First author Huang, Y.; Durall, R. T.; Luong, N. M.; Hertzler, H. J.; Huang, J.; Gokhale, P. C.; Leeper, B. A.; Persky, N. S.; Root, D. E.; Anekal, P. V.; Montero Llopis, P. D.; David, C. N.; Kutok, J. L.; Raimondi, A.; Saluja, K.; Luo, J.; Zahnow, C. A.; Adane, B.; Stegmaier, K.; Hawkins, C. E.; Ponne, C.; Le, Q.; Shapiro, G. I.; Lemieux, M. E.; Eagen, K. P.; French, C. A.
Journal medRxiv
Published Aug 16, 2023
DOI 10.1101/2023.08.15.553204
Devices mentioned K822496, K831119, K831329, K874421, K874422, K874423, K874424
Product codes mentioned DRX, FZS, HAW, JIT, JJH, JJQ, MVU, PFF, PFT

At a glance

  • 1–9 FDA submissions mentioned
  • 1–9 Product codes mentioned

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Literature

Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.

Source: Publisher and PubMed metadata; device mentions identified by Orca1

Browse all Literature